Dean Y. Li - 01 Jul 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
01 Jul 2022
Transactions value $
$0
Form type
4
Filing time
06 Jul 2022, 17:51:06 UTC
Previous filing
16 Jun 2022
Next filing
05 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +1.41K +0.23% $0.00 619K 01 Jul 2022 Direct F1
holding RXRX Class A Common Stock 1.32M 01 Jul 2022 By Dean Y. Li 2021 GRAT
holding RXRX Class A Common Stock 1.32M 01 Jul 2022 By Dean Y. Li 2021 GRAT
holding RXRX Class A Common Stock 1.42M 01 Jul 2022 By Dean Li and Ruth Li Revocable Trust
holding RXRX Class A Common Stock 450K 01 Jul 2022 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.